These results are encouraging to explore the role and effect of ADC targeting PTGFRN for cancers such as mesothelioma and pediatric medulloblastoma, which we have found to both express PTGFRN, and have limited therapeutic options. The gene discussed is PTGFRN; the disease is medulloblastoma.